Bioactivity:

Imatinib is a multi-target inhibitor of v-Abl, c-Kit, and PDGFR (IC50: 0.6 _M, 0.1 _M, and 0.1 _M, respectively). Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and a number of other malignancies.

CAS nr:

862366-25-4

Purity:

98%

Molecular Weight:

530,06

SMILES:

CC1C=CC(=CC1NC2=NC=CC(=N2)C3=CN=CC=C3)NC(=O)C4=CC=C(C=C4)CN5CCN(CC5)C.Cl

Formula:

C29H32ClN7O

Pathway:

Others

Target:

Others